BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12679308)

  • 1. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
    Simmons R; Thevarajah S; Brennan MB; Christos P; Osborne M
    Ann Surg Oncol; 2003 Apr; 10(3):242-7. PubMed ID: 12679308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
    Choi SH; Barsky SH; Chang HR
    Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
    Kern KA
    J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
    Simmons RM; Smith SM; Osborne MP
    Breast J; 2001; 7(3):181-3. PubMed ID: 11469932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of lymph node status in male breast cancer patients: a role for sentinel lymph node biopsy.
    Albo D; Ames FC; Hunt KK; Ross MI; Singletary SE; Kuerer HM
    Breast Cancer Res Treat; 2003 Jan; 77(1):9-14. PubMed ID: 12602900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
    Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
    J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the adverse reactions associated with isosulfan blue versus methylene blue dye in sentinel lymph node biopsy for breast cancer.
    Thevarajah S; Huston TL; Simmons RM
    Am J Surg; 2005 Feb; 189(2):236-9. PubMed ID: 15720998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue dye--a safe and effective alternative for sentinel lymph node localization.
    Varghese P; Abdel-Rahman AT; Akberali S; Mostafa A; Gattuso JM; Carpenter R
    Breast J; 2008; 14(1):61-7. PubMed ID: 18186867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.
    Nour A
    Breast J; 2004; 10(5):388-91. PubMed ID: 15327490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimization of sentinel lymph node identification techniques in the Indian setting: A randomized clinical trial.
    Seenu V; Suhani S; Srivastava A; Parshad R; Mathur S; Kumar R
    Indian J Cancer; 2019; 56(2):114-118. PubMed ID: 31062728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
    Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
    Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intradermal radioisotope is superior to peritumoral blue dye or radioisotope in identifying breast cancer sentinel nodes.
    Lin KM; Patel TH; Ray A; Ota M; Jacobs L; Kuvshinoff B; Chung M; Watson M; Ota DM
    J Am Coll Surg; 2004 Oct; 199(4):561-6. PubMed ID: 15454139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE;
    Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
    Knackstedt RW; Knackstedt T; Gastman B
    J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.
    Kargozaran H; Shah M; Li Y; Beckett L; Gandour-Edwards R; Schneider PD; Khatri VP
    J Surg Res; 2007 Nov; 143(1):126-9. PubMed ID: 17950081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
    Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
    Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
    Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
    Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trend analysis of the relative value of blue dye and isotope localization in 2,000 consecutive cases of sentinel node biopsy for breast cancer.
    Derossis AM; Fey J; Yeung H; Yeh SD; Heerdt AS; Petrek J; VanZee KJ; Montgomery LL; Borgen PI; Cody HS
    J Am Coll Surg; 2001 Nov; 193(5):473-8. PubMed ID: 11708502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous contrast-enhanced ultrasound for localization and diagnosis of sentinel lymph node in early breast cancer.
    Liu J; Liu X; He J; Gou B; Luo Y; Deng S; Wen H; Zhou L
    Sci Rep; 2019 Sep; 9(1):13545. PubMed ID: 31537856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients?
    Chung A; Yu J; Stempel M; Patil S; Cody H; Montgomery L
    Ann Surg Oncol; 2008 Oct; 15(10):2728-33. PubMed ID: 18688679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.